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Editors: Anton N. Sidawy and Bruce A. PerlerDifferential outcomes of carotid stenting and
endarterectomy performed exclusively by vascular
surgeons in the Carotid Revascularization Endarterectomy
versus Stenting Trial (CREST)
Carlos H. Timaran, Vito A. Mantese, Mahmoud Malas, O.
William Brown, Brajesh K. Lal, Wesley S. Moore, Jenifer H.
Voeks, Thomas G. Brott
Objective: Outcomes in the Carotid Revascularization
Endarterectomy versus Stenting Trial (CREST) did not differ
between carotid artery stenting (CAS) and carotid endar-
terectomy (CEA) for the composite primary end point of
stroke, myocardial infarction (MI), or death during the
periprocedural period or ipsilateral stroke within 4 years.
Rigorous credentialing and training of interventionists,
including vascular surgeons, were required for the
randomization phase of CREST. Because the lead-in phase of
CREST had suggested higher perioperative risks after CAS
performed by vascular surgeons, the purpose of this anal-
ysis was to examine differences in outcomes after
randomization between CAS and CEA performed by vascular
surgeons.
Methods: CREST is a prospective randomized controlled
trial with blinded end point adjudication. Vascular surgeons
performed 237 (21%) of the CAS procedures and 765 (65%)
of the CEA procedures among 2320 patients who received
their assigned treatment. Proportional hazards analyses
were used to estimate the relative efﬁcacy of CAS vs CEA for
the composite primary end point and also for stroke and
death.
Results: Among 2502 randomized patients, 1321 (53%)
were symptomatic and 1181 (47%) were asymptomatic. For
procedures performed exclusively by vascular surgeons, the
primary end point did not differ between CAS and CEA at 4-
year follow-up (6.2% vs 5.6%, respectively; hazard ratio
[HR], 1.30; 95% conﬁdence interval [CI], 0.70-2.41; P ¼ .41)
In this subgroup, the periprocedural stroke and death rates
were higher after CAS than CEA for symptomatic patients
(6.1% vs 1.3%; P ¼ .01). Asymptomatic patients also had
slightly higher stroke and death rates after CAS (2.6% vs
1.1%; P ¼ .20), although this difference did not reach
statistical signiﬁcance. Conversely, cranial nerve injuries
(0.0% vs 5.0%; P < .001) were less frequent after CAS than
CEA. The MI rates were slightly lower after CAS (1.3% vs
2.6%; P ¼ .24). In performing CAS, vascular surgeons had
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0.99; 95% CI, 0.50-2.00) after adjusting for age, sex, and
symptomatic status. Vascular surgeons also had similar
results after CEA for the periprocedural primary end point
compared with other surgeons (HR, 0.73; 95% CI, 0.42-
1.27).
Conclusions: When performed by surgeons, CAS and CEA
have similar net outcomes, although the periprocedural
risks vary (lower stroke with CEA and lower MI with CAS).
These data suggest that appropriately trained vascular
surgeons may safely offer both CEA and CAS for the
prevention of stroke. The remarkably low stroke and death
rates after CEA performed by vascular surgeons in CREST,
particularly among symptomatic patients, represent the
best outcomes ever reported after carotid interventions
from a randomized controlled trial. ClinicalTrials.gov iden-
tiﬁer: NCT0000473.Assessing the impact of distal protection ﬁlter design
characteristics on 30-day outcomes of carotid artery
stenting procedures
Natasha A. Loghmanpour, Gail M. Siewiorek, Kelly M.
Wanamaker, Satish C. Muluk, Rabih Chaer, Mark H. Wholey,
Ender A. Finol
Objective: This study aims to review retrospectively the
records of patients treated with carotid artery stenting
(CAS) to investigate the potential correlations between
clinical variables, distal protection ﬁlter (DPF) type and
characteristics, and 30-day peri-/postprocedural outcomes.
Methods: This is a multicenter, single-arm, nonrandomized
retrospective study of patients who underwent ﬁlter-pro-
tected CAS in the Pittsburgh, Pennsylvania, region between
July 2000 and May 2011. Analysis of peri-/postprocedural
complications included myocardial infarction, transient
ischemic attacks (TIA), stroke, death, and a composition of
all adverse events (AEs). Filter characteristics for Accunet
(Abbott Vascular, Santa Clara, Calif; n ¼ 429 [58.8%]),
Angioguard (Cordis Endovascular, Miami Lakes, Fla; n ¼ 114
[15.6%]), FilterWire (Boston Scientiﬁc, Natick, Mass; n ¼
113 [15.5%]), Spider (ev3 Endovascular, Plymouth, Minn;
n ¼ 45 [6.2%]), and Emboshield (Abbott Vascular; n ¼ 24
[3.3%]) were previously determined in vitro and were used
to ﬁnd correlations with CAS procedural outcomes. Both
univariate and multivariate analyses were performed, as
well as goodness-of-ﬁt tests to ﬁnd multivariate correlations
with procedural outcomes.
Results: In total, 731 CAS procedures using six different
DPFs were analyzed. Peri-/postprocedural AEs included 19
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(0.1%), 19 deaths (3.6%), and a total of 61 patients with
complications (8.3%). Univariate analysis for ﬁlter design
characteristics showed that the composite of AE was
negatively associated with both vascular resistance (P ¼ .01)
and eccentricity (P ¼ .02) and was positively associated with
porosity (P ¼ .0007), number of pores (P ¼ .005), and pore
density (P ¼ .001). Multivariate analysis and the goodness-
of-ﬁt test revealed that patients with a history of congestive
heart failure, stroke, and TIA (each with odds ratio >1) led
to a good-ﬁt model P value of .72 for peri-/postprocedural
AEs. Multivariate analysis was inconclusive for all ﬁlter
design characteristics.
Conclusions: The following ﬁlter design characteristics are
independently signiﬁcant for minimizing peri-/post-
procedural AEs: higher vascular resistance, concentric in
shape, greater capture efﬁciency, lower porosity, lower
number of pores, and lower pore density. Lower porosity and
smaller wall apposition were also found to be independently
signiﬁcant for minimization of peri-/postprocedural TIAs.
This information can be used when considering the desirable
design characteristics of future DPFs.)B-type natriuretic peptide predicts postoperative cardiac
events and mortality after elective open abdominal aortic
aneurysm repair in the short term, intermediate term, and
long term
Gavin J. Bryce, Christopher J. Payne, Simon C. Gibson,
Dominique S. Byrne, Christian Delles, John McClure, David
B. Kingsmore
Objective: The aim of this study was to determine if a single
preoperative B-type natriuretic peptide (BNP) level corre-
lated with perioperative cardiac events, cardiac death, and
all-cause mortality in elective open abdominal aortic aneu-
rysm (AAA) repair in the short term, intermediate term, and
long term.
Methods: A prospective, 2-year multicenter observational
cohort study in the three vascular units in Glasgow was
performed. All patients who were admitted for elective
open AAA repair were recruited. Preoperative BNP levels
were performed and batch analyzed at the end of the study.
Postoperative screening for cardiac events (nonfatal
myocardial infarction and cardiac death) was performed at
2, 5, and 30 days. Follow-up for all-cause mortality was
sustained to a minimum of 3 years, where possible.
Results: A total of 106 of 111 patients were recruited.
Median BNP concentrations were higher in the 16 patients
(15%) with immediate postoperative cardiac events (P ¼
.001) and the ﬁve with cardiac death (P ¼ .043). Area under
the receiver-operating characteristic (AUC) curve analysis
indicated BNP concentrations of 99.5 pg/mL best predicted
cardiac events (AUC, 0.927), and 448 pg/mL predicted
cardiac death (AUC, 0.963). BNP also predicted all-cause
mortality in the short-term (P ¼ .028), intermediate-term (P
< .001), and long-term (P < .001) postoperative periods.Conclusions: Preoperative serum BNP concentration pre-
dicted postoperative cardiac events, cardiac death, and all-
cause mortality in patients undergoing elective open AAA
repair on short-term, intermediate-term, and long-term
follow-up on an individual basis with greater accuracy than
currently available risk prediction tools.Comparison of fenestrated endovascular and open repair
of abdominal aortic aneurysms not suitable for standard
endovascular repair
Rana Canavati, Alistair Millen, John Brennan, Robert K.
Fisher, Richard G. McWilliams, Jagjeeth B. Naik, Srinivasa R.
Vallabhaneni
Background: Abdominal aortic aneurysms that are unsuit-
able for a standard endovascular repair (EVAR) could be
considered for fenestrated endovascular repair (f-EVAR).
The aim of this study was to conduct a risk-adjusted
retrospective concurrent cohort comparison of f-EVAR and
open repair for such aneurysms.
Methods: All patients who underwent repair of an
abdominal aortic aneurysm that was unsuitable for a stan-
dard EVAR due to inadequate neck within one institution
between January 2006 and December 2010 were identiﬁed.
Case notes were retrieved for clinical data, Vascular Physi-
ological and Operative Severity Score for enUmeration of
Mortality and Morbidity (V-POSSUM) score, and aneurysm
morphology. Computed tomography scans were reviewed
to establish aneurysm morphology.
Results: A total of 107 patients were identiﬁed. The open
surgery cohort included 54 patients (35 men) who were
a median age of 72 years (interquartile range [IQR], 9.5;
range, 60-86 years). The aortic cross-clamp was infrarenal in
20 patients, suprarenal or above in 21, and inter-renal in
eight. Postoperatively, 63 major complications were noted
in 30 patients, nine of whom required 16 reinterventions.
Cumulative hospital stay of the cohort was 1170 days
(median, 12; IQR, 13; range, 1-205 days) of which 234 days
(median, 28; IQR, 36; range, 1-77 days) were in the inten-
sive therapy unit (ITU). Perioperative mortality was 9.2%
(n ¼ 5), exactly as estimated by V-POSSUM. The f-EVAR
cohort included 53 patients (47 men) who were a median
age of 76 years (IQR, 11.50; range, 55-87 years). Two
fenestrations and one scallop was the most frequent
conﬁguration (n ¼ 31). Postoperatively, 37 major compli-
cations were noted in 18 patients, six requiring reinter-
vention. Hospital stay was 559 days (median, 7; IQR, 4.5;
range, 4-64 days), of which 31 days (median, 4; IQR, 10.5;
range, 1-15 days) were in the ITU. Two patients died peri-
operatively (3.7%), resulting in an observed crude absolute
risk reduction of 5.5% compared with open repair. The V-
POSSUM estimated perioperative death in ﬁve patients
(9.4%) in the f-EVAR cohort. In a hypothetic scenario of the
f-EVAR cohort undergoing open repair, V-POSSUM esti-
mated seven deaths (13.2%), resulting in an estimated risk-
adjusted absolute risk reduction due to f-EVAR of 9.5%.
194 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 2 February/2013Conclusions: In this group of patients, f-EVAR reduced
mortality and morbidity substantially compared with open
repair and also reduced total hospital stay and ITU utilization.Five-year outcomes of an abdominal aortic aneurysm
screening program at a regional Veterans Affairs health
care system
Kevin C. Chun, Kai Y. Teng, Elyse N. Van Spyk, John G. Car-
son, Eugene S. Lee
Objective: In 2007, Medicare guidelines were established to
identify persons at risk for the presence of an abdominal
aortic aneurysm (AAA). The purpose of this study is to
evaluate the 5-year outcomes of an AAA screening program
in a regional Veterans Affairs (VA) health care system.
Methods: Data were extracted from a regional VA health
care network identifying all veteran males 65 to 75 years of
age who smoked at least 100 cigarettes during their life-
time. In 2007, an AAA screening mandate was implemented
allowing patients meeting screening criteria to be evaluated
for AAA as part of the patient’s health maintenance. AAA is
identiﬁed as an aortic diameter size of 3.0 cm or greater.
Clinician adherence to screening protocols and referral to
a vascular surgeon for aneurysms >5.5 cm were also
evaluated.
Results: A total of 9751 patients (71.5  5.6 standard
deviation years of age) were screened for an AAA over a 5-
year period from January 1, 2007 to December 31, 2011. A
total of 698 aneurysms (7.1%) were found. Referrals to
a vascular surgeon were made on 45 patients with aneu-
rysms >5.5 cm. Over a 5-year period, a total of 2754
patients (28.2%) were inappropriately screened: 416
patients were under 65 years old, 2243 patients were over
75 years old, 36 patients were women, and 123 patients
without aneurysms had multiple screenings. In 2007, during
the ﬁrst year of implementation, 39.2% of patients were
inappropriately screened. Over the next 4 years, inappro-
priate screenings decreased with 33.7% in 2008, 28.6% in
2009, 17.7% in 2010, and 14.3% in 2011.
Conclusions: A large AAA screening program at the VA
detects more aneurysms, but at smaller diameters than that
published in clinical trials. Over time, the number of inap-
propriate AAA screenings has continued to decrease,
demonstrating greater awareness and application of the
AAA screening guidelines by primary care providers.
Developing surveillance guidelines for small and medium
aneurysms is a potential area for future research.The outcome of failed endografts inserted for superﬁcial
femoral artery occlusive disease
Mare M.A. Lensvelt, Bahar Golchehr, Rombout R. Kruse,
Suzanne Holewijn, Laurens A. van Walraven, Wilbert M.
Fritschy, Clark J. Zeebregts, Michel M.P.J. Reijnen
Objective: Endografts represent a relatively new treatment
modality for occlusive disease of the superﬁcial femoral
artery, with promising results. However, endografts mayocclude collateral arteries, which may affect outcome in
case of failure. The purpose of this study was to analyze the
clinical outcome of failed endografts in patients with
superﬁcial femoral artery occlusive disease.
Methods: All patients treated with one or more polytetra-
ﬂuorethylene-covered stents between November 2001 and
December 2011 were prospectively included in a database.
Patients with a failure of the endograft were retrospectively
analyzed. Clinical and hemodynamic parameters were
assessed before the initial procedure and at the time of
failure. Outcome of secondary procedures was analyzed.
Results: Among the 341 patients who were treated during
the study period, 49 (14.4%) failed during follow-up. Mean
(standard deviation) Rutherford category at failure did not
differ from the category as scored before the initial proce-
dure (3.1 [1.3] vs 3.3 [0.6]; P ¼ .33). Forty-three percent of
patients (n ¼ 21) presented with the same Rutherford
category as before the initial procedure, 37% (n ¼ 18) with
an improved category, and 20% (n ¼ 10) with a deteriorated
category. The ankle-brachial index was signiﬁcantly lower at
the time of failure (0.66 [0.19] vs 0.45 [0.19[; P <.002).
Seventy-six percent of patients with a failure needed
secondary surgery, of which 25% were below knee. The 1-
year primary, primary-assisted, and secondary patency rates
of secondary bypasses were 55.1%, 62.3%, and 77.7%,
respectively. The amputation rate was 4.1% (n ¼ 2).
Conclusions: Failure of endografts is not associated with
a deterioration in clinical state and is related to a low ampu-
tation rate. The hypothesis that covered stents do not affect
options for secondary reconstructions could not be conﬁrmed,
as 25% of patients with a failure underwent a below-knee
bypass. Secondary surgical bypasses are correlated with poor
patency. The amputation rate after failure is low.Angiosome-targeted infrapopliteal endovascular
revascularization for treatment of diabetic foot ulcers
Maria Söderström, Anders Albäck, Fausto Biancari, Kimmo
Lappalainen, Mauri Lepäntalo, Maarit Venermo
Objective: Because of the prolonged healing time of dia-
betic foot ulcers, methods for identifying ways to expedite
the ulcer healing process are needed. The angiosome
concept delineates the body into three-dimensional blocks
of tissue fed by speciﬁc source arteries. The aim of this
study was to evaluate the beneﬁt of infrapopliteal endo-
vascular revascularization guided by an angiosome model of
perfusion in the healing process of diabetic foot ulcers.
Methods: A total of 250 consecutive legs with diabetic foot
ulcers in 226 patients who had undergone infrapopliteal
endovascular revascularization in a single center were
evaluated. Patient records and periprocedural leg angio-
grams were reviewed. The legs were divided into two
groups depending on whether direct arterial ﬂow to the site
of the foot ulcer based on the angiosome concept was
achieved (direct group) or not achieved (indirect group).
Ulcer healing time was compared between the two groups.
A propensity score was used for adjustment of differences
Abstracts 195in pretreatment covariables in multivariate analysis and for
1:1 matching.
Results: Direct ﬂow to the angiosome feeding the ulcer area
was achieved in 121 legs (48%) compared with indirect
revascularization in 129 legs. Foot ulcers treated with
angiosome-targeted infrapopliteal percutaneous trans-
luminal angioplasty healed better. The ulcer healing rate
was mean (standard deviation) 72% (5%) at 12 months for
the direct group compared with 45% (6%) for the indirect
group (P < .001). When adjusted for propensity score, the
direct group still had a signiﬁcantly better ulcer healing rate
than the indirect group (hazard ratio, 1.97; 95% conﬁdence
interval, 1.34-2.90; P ¼ .001).
Conclusions: Attaining a direct arterial ﬂow based on the
angiosome model of perfusion to the foot ulcer appears to
be important for ulcer healing in diabetic patients.Prediction of graft patency and mortality after distal
revascularization and interval ligation for hemodialysis
access-related hand ischemia
Salvatore T. Scali, Catherine K. Chang, Dan Raghinaru,
Michael J. Daniels, Adam W. Beck, Robert J. Feezor, Scott A.
Berceli, Thomas S. Huber
Objective: The treatment goals of access-related hand
ischemia (ARHI) are to reverse symptoms and salvage the
access. Many procedures have been described, but the
optimal treatment strategy remains unresolved. In an effort
to guide clinical decision making, this study was undertaken
to document our outcomes for distal revascularization and
interval ligation (DRIL) and to identify predictors of bypass
patency and patient mortality.
Methods: A retrospective review was performed of all
patients who underwent DRIL at the University of Florida
from 2002 to 2011. Diagnosis of ARHI was based primarily
upon clinical symptoms with noninvasive studies used to
corroborate in equivocal cases. Patient demographics,
procedure-outcome variables, and reinterventions were
recorded. Bypass patency and mortality were estimatedusing cumulative incidence and Kaplan-Meier methodology,
respectively. Cumulative incidence and Cox regression
analysis were performed to determine predictors of bypass
patency and mortality, respectively.
Results: A total of 134 DRILs were performed in 126 patients
(mean [standard deviation] age, 57 [12] years) following
brachial artery-based access.The postoperative complication
rate was 27% (19% wound), and 30-day mortality was 2%.
The wrist-brachial index and digital brachial index increased
0.31 (0.25) and 0.25 (0.29), respectively. Symptoms resolved
in 82% of patients, and 85% continued to use their access.
Cumulative incidences ( standard error of the mean) of loss
of primary and primary-assisted patency rates were 5% 2%
and 4%  2% at 1 year and 22%  5% and 18%  5% at 5
years, respectively, with mean follow-up of 14.8 months.
Univariate predictors of primary patency failure were DRIL
complications (odds ratio [OR], 3.3; 95% conﬁdence interval
[CI], 1.2-8.9; P ¼ .02), conﬁguration other than brachioba-
silic/brachiocephalic autogenous access (OR, 3.4; 95% CI,
1.4-8.3; P ¼ .009), and two or more prior access attempts
(OR, 4.1; 95% CI, 1.6-10.4; P ¼ .004). Brachiocephalic access
conﬁguration (OR, 0.2; 95% CI, 0.04-0.8; P ¼ .02) and
autogenous vein conduit (OR, 0.2; 95% CI, 0.06-0.58; P ¼
.004) were predictors of improved bypass patency. All-cause
mortality was 28% and 79% at 1 and 5 years, respectively.
Multivariable predictors of mortality were age >40 (hazard
ratio [HR], 8.3; 95% CI, 2.5-33.3; P¼ .0004), grade 3 ischemia
(HR, 2.6; 95% CI, 1.5-4.6; P¼ .0008), complication from DRIL
(HR, 2.4; 95% CI, 1.3-4.5; P¼ .004), and smoking history (HR,
2.2; 95% CI, 1.3-4; P ¼ .007). Patients with no prior access
attempts had lower predicted mortality (HR, 0.5; 95% CI, 0.3-
0.9; P ¼ .02).
Conclusions: The DRIL procedure effectively improves distal
perfusion and reverses the symptoms of ARHI while
salvaging the access, but the long-term survival of these
patients is poor. Given the poor survival, preoperative risk
stratiﬁcation is critical. Patients at high risk for DRIL failure
and mortality may be best served with alternate remedial
procedures.
